In EGFR mutant lung cancer cells, H3K9 demethylation mediated upregulation of BCAT1 and subsequent metabolic reprogramming, which promotes TKI (lethal EGFR tyrosine kinase inhibitors) resistance through attenuating reactive oxygen species (ROS) accumulation [61]. The gene discussed is EGFR; the disease is lung cancer.